Randomized Phase II Trial of Sulindac for Lung Cancer Chemoprevention

INTRODUCTION: Sulindac represents a promising candidate agent for lung cancer chemoprevention, but clinical trial data have not been previously reported. We conducted a randomized, phase II chemoprevention trial involving current or former cigarette smokers (≥ 30 pack-years) utilizing the multi-cent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Limburg, Paul J., Mandrekar, Sumithra J., Aubry, Marie Christine, Ziegler, Katie L. Allen, Zhang, Jun, Yi, Joanne E., Henry, Michael, Tazelaar, Henry D., Lam, Stephen, McWilliams, Annette, Midthun, David E., Edell, Eric S., Rickman, Otis B., Mazzone, Peter, Tockman, Melvyn, Beamis, John F., Lamb, Carla, Simoff, Michael, Loprinzi, Charles, Szabo, Eva, Jett, James
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566344/
https://ncbi.nlm.nih.gov/pubmed/23261228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2012.11.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados